WHO approves Sinopharm jab in potential boost to Covax pipeline


THE World Health Organisation (WHO) approved for emergency use a Covid-19 vaccine from China’s state-owned drugmaker Sinopharm, bolstering Beijing’s push for a bigger role in inoculating the world.

The vaccine, one of two main Chinese coronavirus vaccines that have been given to hundreds of millions of people in China and elsewhere, is the first developed by a non-Western country to win WHO backing.

It is also the first time the WHO has given emergency use approval to a Chinese vaccine for any infectious disease.

A WHO emergency listing is a signal to national regulators that a product is safe and effective.

It also allows it to be included in Covax programme which have hit supply problems.

“This expands the list of Covid-19 vaccines that Covax can buy, and gives countries confidence to expedite their own regulatory approval, and to import and administer a vaccine, ” WHO director-general Tedros Adhanom Ghebreyesus said.

Senior WHO adviser Bruce Aylward said it would be up to Sinopharm to say how many doses of its vaccine it can provide to the programme, but added: “They are looking at trying to provide substantial support, make substantial doses available while at the same time of course trying to serve China’s population.”

The WHO had already given emergency approval to Covid-19 vaccines developed by Pfizer-BioNTech, AstraZeneca, Johnson & Johnson and, last week, Moderna.

“This signifies that the safety, efficacy and accessibility of Sinopharm CNBG’s Covid-19 vaccine meet the requirements of WHO standards, which will contribute more Chinese power to the global fight against the Covid-19 pandemic, ” Sinopharm said in a social media statement published yesterday.

The decision to approve Sinopharm’s vaccine was taken by WHO’s technical advisory group, which met since April 26 to review the latest clinical data and manufacturing practices.

The WHO has said it could reach a decision on China’s other main Covid-19 vaccine, made by Sinovac Biotech, next week. — Reuters

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 46
Cxense type: free
User access status: 3
   

Next In Aseanplus News

UN official warns Myanmar at risk of 'large-scale' civil war as blast near junta-Army office kills two
Hong Kong pro-democracy media outlet Apple Daily's top media executives denied bail under security law
More than half of Singapore population have received first dose of Covid-19 vaccine, says Minister
Indonesian police arrest four suspected terrorists from group affiliated to ISIS
Thailand and Malaysia launch cross-border QR payment
Philippine central bank says has tools to cushion Fed taper impact
Breaking new grounds: Vietnam and Indian forge cooperation in UN Peacekeeping
Flower power: Myanmar protesters wear flowers to mark Suu Kyi's birthday
Malaysia's Sunway plans to sell healthcare stake to Singapore's GIC, says report
Indonesia carrier Garuda's shares halted over bond default

Stories You'll Enjoy


Vouchers